Concepedia

Peter Bialek

PB

Statistics

Publications

14

Citations

3.9K

H-Index

14

Active since

2002

Affiliations

Pfizer (United States)(Current)

Baylor College of Medicine

Washington University in St. Louis

Western University

Columbia University

Peter Bialek is an author at Pfizer (United States) specializing in medicine, osteoporosis, and cell biology.

Top concepts

Publications per year

2002–2017

14

Publications

14

Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation

Donald A. Glass, Peter Bialek, Jong Deok Ahn et al. · Developmental Cell · 2005 · 1.5K citations

, , +4

ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology

Xiangli Yang, Koichi Matsuda, Peter Bialek et al. · Cell · 2004 · 816 citations · Full text

, , +10

A Twist Code Determines the Onset of Osteoblast Differentiation

Peter Bialek, Britt Kern, Xiangli Yang et al. · Developmental Cell · 2004 · 682 citations · Full text

, , +8

Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium

Eiichi Hinoi, Peter Bialek, You‐Tzung Chen et al. · Genes & Development · 2006 · 160 citations · Full text

Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice

Robin Varghese, Anthony D. Gagliardi, Peter Bialek et al. · Endocrinology · 2002 · 130 citations

Rows per page

1–5 of 14